PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31976335-10	2019	Conclusions: These results suggested that SCU can be an oral drug to alleviate microvascular dysfunction of DR and exerts its antiangiogenic effects by inhibiting the expression of the crosstalk of VEGF, p-ERK, p-FAK, and p-Src.	scutellarin	42-45	SRC proto-oncogene, non-receptor tyrosine kinase	Rattus norvegicus	224-227